Poland
· Delayed Price · Currency is PLN Medicalgorithmics Statistics
Total Valuation
Medicalgorithmics has a market cap or net worth of PLN 242.85 million. The enterprise value is 230.67 million.
| Market Cap | 242.85M |
| Enterprise Value | 230.67M |
Important Dates
The last earnings date was Thursday, September 19, 2024.
| Earnings Date | Sep 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Medicalgorithmics has 9.95 million shares outstanding. The number of shares has increased by 43.31% in one year.
| Shares Outstanding | 9.95M |
| Shares Change (YoY) | +43.31% |
| Shares Change (QoQ) | -24.09% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 18.62% |
| Float | 4.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.26 |
| PB Ratio | 2.74 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -37.80 |
| EV / Sales | 5.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -26.25 |
Financial Position
The company has a current ratio of 3.07, with a Debt / Equity ratio of 4.72.
| Current Ratio | 3.07 |
| Quick Ratio | 2.22 |
| Debt / Equity | 4.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.48 |
| Interest Coverage | -104.28 |
Financial Efficiency
Return on equity (ROE) is -7.02% and return on invested capital (ROIC) is -4.55%.
| Return on Equity (ROE) | -7.02% |
| Return on Assets (ROA) | -3.56% |
| Return on Capital (ROIC) | -4.55% |
| Revenue Per Employee | 323,542 |
| Profits Per Employee | -50,858 |
| Employee Count | 120 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 2.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.11% in the last 52 weeks. The beta is 0.54, so Medicalgorithmics's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -24.11% |
| 50-Day Moving Average | 25.43 |
| 200-Day Moving Average | 27.44 |
| Relative Strength Index (RSI) | 53.69 |
| Average Volume (20 Days) | 13,676 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicalgorithmics had revenue of PLN 38.83 million and -6.10 million in losses. Loss per share was -0.61.
| Revenue | 38.83M |
| Gross Profit | 11.32M |
| Operating Income | -6.78M |
| Pretax Income | -6.56M |
| Net Income | -6.10M |
| EBITDA | -7.05M |
| EBIT | -6.78M |
| Loss Per Share | -0.61 |
Balance Sheet
The company has 16.37 million in cash and 4.19 million in debt, giving a net cash position of 12.19 million or 1.22 per share.
| Cash & Cash Equivalents | 16.37M |
| Total Debt | 4.19M |
| Net Cash | 12.19M |
| Net Cash Per Share | 1.22 |
| Equity (Book Value) | 88.64M |
| Book Value Per Share | 8.91 |
| Working Capital | 24.84M |
Cash Flow
In the last 12 months, operating cash flow was -8.32 million and capital expenditures -465,000, giving a free cash flow of -8.79 million.
| Operating Cash Flow | -8.32M |
| Capital Expenditures | -465,000 |
| Free Cash Flow | -8.79M |
| FCF Per Share | -0.88 |
Margins
Gross margin is 29.16%, with operating and profit margins of -17.46% and -15.72%.
| Gross Margin | 29.16% |
| Operating Margin | -17.46% |
| Pretax Margin | -16.91% |
| Profit Margin | -15.72% |
| EBITDA Margin | -18.15% |
| EBIT Margin | -17.46% |
| FCF Margin | -22.63% |
Dividends & Yields
Medicalgorithmics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.31% |
| Shareholder Yield | -43.31% |
| Earnings Yield | -2.51% |
| FCF Yield | -3.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medicalgorithmics has an Altman Z-Score of 4.9.
| Altman Z-Score | 4.9 |
| Piotroski F-Score | n/a |